Advanced design and development of nanoparticle/microparticle dual-drug combination lactose carrier-free dry powder inhalation aerosols-Reference-Cited by-同舟云学术

Advanced design and development of nanoparticle/microparticle dual-drug combination lactose carrier-free dry powder inhalation aerosols

Published:2020 Issue:68 Volume:10 Page:41846-41856
ISSN:2046-2069
Container-title:RSC Advances
language:en
Short-container-title:RSC Adv.

Author:

Muralidharan Priya¹²³⁴,Mallory Evan K.¹²³⁴,Malapit Monica¹²³⁴,Phan Hanna¹²³⁴⁵^ORCID,Ledford Julie G.⁵³⁴⁶⁷,Hayes Don⁸⁹¹⁰¹¹⁴,Mansour Heidi M.¹²³⁴⁶^ORCID

Affiliation:

1. The University of Arizona

2. College of Pharmacy

3. Tucson

4. USA

5. The Asthma & Airway Disease Research Center

6. The University of Arizona College of Medicine

7. Department of Cellular & Molecular Medicine

8. The Departments of Pediatrics and Internal Medicine

9. Lung and Heart–Lung Transplant Programs

10. The Ohio State University College of Medicine

11. Columbus

Abstract

Advanced co-spray drying of fluticasone propionate, salmeterol xinafoate, andd-mannitol leads to high-performing inhalable dry powders as molecular mixtures.

Funder

National Institute of Allergy and Infectious Diseases

National Heart, Lung, and Blood Institute

W. M. Keck Foundation

National Science Foundation

College of Pharmacy

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2020/RA/D0RA07203F